Extrapancreatic glucagon and glucagonlike immunoreactivity in depancreatized dogs. A quantitative assessment of secretion rates and anatomical delineation of sources.

The anatomical sites and the rates of extrapancreatic secretion of glucagon and of glucagon-like immunoreactivity (GLI) were assessed in dogs 2 h after pancreatectomy by catheterization of the gastrosplenic and mesenteric veins. Glucagon release from the gastrosplenic area approximated one-fourth that of a normal pancreas and rose from 0.25 to 1.0 ng/kg per min during arginine stimulation. Intestinal glucagon secretion was small and did not respond to arginine, suggesting that the stomach is the only important extrapancreatic source of glucagon. Glucagon concentrations attained by gastrosplenic secretion were in close proportion to those obtained during the administration of exogenous glucagon, indicating similar clearance rates of extrapancreatic and pancreatic glucagon, approximating 10 ml/kg per min.GLI secretion (0.3 ng eq/kg per min) was limited to the intestinal area and was transiently stimulated by arginine and exogenous glucagon. Base-line GLI clearance approximated 1 ml/kg per min. No insulin secretion could be detected. Gastrointestinal glucose uptake rose from 0.56 to 2.2 mg/kg per min after glucagon administration suggesting that as much as 10% of total glucose production can be taken up by the gastrointestinal tract. In two dogs both the stomach and pancreas were removed. Intestinal glucagon release remained small and did not increase during arginine administration. By contrast, GLI release was stimulated by both arginine and exogenous glucagon.

[1]  J. Lefebvre,et al.  [Extrapancreatic glucagon in the dog (author's transl)]. , 1980, Annales d'endocrinologie.

[2]  M. Vranic,et al.  Extrapancreatic glucagon in control of glucose turnover in depancreatized dogs. , 1978, The American journal of physiology.

[3]  P. Lefèbvre,et al.  Factors controlling gastric-glucagon release. , 1977, The Journal of clinical investigation.

[4]  R. Unger,et al.  Properties of immunoreactive glucagon fractions of canine stomach and pancreas. , 1977, The Journal of biological chemistry.

[5]  R. Unger,et al.  EVIDENCE FOR THE PRESENCE OF CLUCAGON-LIKE IMMUNOREACTIVITY (CLI) IN THE PANCREAS1 , 1976 .

[6]  O. V. Nielsen,et al.  Porcine gastric insulin. , 1976, Endocrinology.

[7]  L. Girardier,et al.  Control of A and B cells in vivo by sympathetic nervous input and selective hyper or hypoglycemia in dog pancreas. , 1976, Journal de physiologie.

[8]  M. Vranic,et al.  Measurement and Partial Characterization of Immunoreactive Glucagon in Gastrointestinal Tissues of Dogs , 1976, Diabetes.

[9]  L. Orci,et al.  Gastric A-cell function in insulin-deprived depancreatized dogs. , 1976, Endocrinology.

[10]  E. Blázquez,et al.  Gastric A-cell function in normal dogs. , 1976, The American journal of physiology.

[11]  A. Moody,et al.  Purification and Characterization of a Protein from Porcine Gut with Glucagon-Like Immunoreactivity , 1976, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[12]  S. Bloom,et al.  Glucagon metabolism in man, studies on the metabolic clearance rate and the plasma acute disappearance time of glucagon in normal and diabetic subjects. , 1976, The Journal of clinical endocrinology and metabolism.

[13]  R. Sherwin,et al.  Kinetics of glucagon in man: effects of starvation. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[14]  L. Orci,et al.  Identification of glucagon-producing cells (A cells) in dog gastric mucosa , 1976, The Journal of cell biology.

[15]  R. Unger The Banting Memorial Lecture 1975: Diabetes and the Alpha Cell , 1976, Diabetes.

[16]  R. Unger,et al.  Heterogeneity of plasma glucagon immunoreactivity in normal, depancreatized, and alloxan-diabetic dogs. , 1975, Metabolism: clinical and experimental.

[17]  L. Orci,et al.  Identification of glucagon in the gastrointestinal tract. , 1975, The Journal of clinical investigation.

[18]  M. Chou,et al.  Persistent pancreatic glucagon but not insulin response to arginine in pancreatectomized dogs. , 1975, Endocrinology.

[19]  G. Weir,et al.  High molecular weight glucagon-like immunoreactivity in plasma. , 1975, The Journal of clinical endocrinology and metabolism.

[20]  M. Vranic,et al.  Increased “Glucagon Immunoreactivity” in Plasma of Totally Depancreatized Dogs , 1974, Diabetes.

[21]  P. Foà,et al.  Plasma Glucose, Insulin, Pancreatic, and Enteroglucagon Levels in Normal and Depancreatized Dogs 1 , 1974, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[22]  L. Orci,et al.  Glucagon release induced by pancreatic nerve stimulation in the dog. , 1973, The Journal of clinical investigation.

[23]  T. Fujita,et al.  Endocrine cells in human jejunum and ileum: an electron microscope study of biopsy materials. , 1973, Archivum histologicum Japonicum = Nihon soshikigaku kiroku.

[24]  R. Assan,et al.  Structure/Function and Structure/Immunoreactivity Relationships of the Glucagon Molecule and Related Synthetic Peptides , 1972, Diabetes.

[25]  W. A. Müller,et al.  Studies of pancreatic alpha cell function in normal and diabetic subjects. , 1970, The Journal of clinical investigation.

[26]  R. Unger,et al.  Large glucagon immunoreactivity in extracts of pancreas. , 1970, The Journal of biological chemistry.

[27]  V. Herbert,et al.  Coated charcoal immunoassay of insulin. , 1965, The Journal of clinical endocrinology and metabolism.

[28]  W. Cannon ORGANIZATION FOR PHYSIOLOGICAL HOMEOSTASIS , 1929 .